Placed in the treatment area
Lanluma is administered into carefully selected areas based on the treatment plan and anatomy.
Lanluma is an injectable poly-L-lactic acid (PLLA) collagen biostimulator used for selected facial and body concerns. Rather than creating an immediate filler-style result alone, treatment is designed around a gradual collagen response that develops over time.
Lanluma is injected into selected treatment areas following an individual assessment. The aim is to stimulate the body’s own collagen response, with the treatment plan adapted according to whether the face or body is being treated.
Lanluma is administered into carefully selected areas based on the treatment plan and anatomy.
Following treatment, the PLLA particles are intended to stimulate new collagen formation within the treated tissue.
The visible result develops progressively as the collagen response evolves, rather than representing the final result immediately after injection.
Treatment planning depends on anatomy, the amount of correction sought and whether Lanluma is appropriate for the individual patient.
Facial Lanluma can be considered where the goal is gradual support and contour improvement rather than an immediate filler-style change.
For the body, Lanluma may be used to address contour, volume distribution and selected skin-quality concerns following assessment.
The exact plan is individual. The clinic's current guidance notes that facial treatment may involve fewer sessions than larger body areas, with follow-up based on the response achieved.
The practitioner assesses the area, your expectations and whether a collagen biostimulator is an appropriate option.
The planned areas are assessed and prepared before the injectable treatment begins.
The clinic's current information states that the procedure is generally completed within an hour.
Changes are progressive. The clinic currently notes that fuller effects may become more apparent over approximately two to three months.
Lanluma should be approached as a gradual treatment. The amount of change, number of sessions and duration of effect vary between patients.
Lanluma is a collagen-stimulating treatment. Early post-treatment appearance is not the same as the final outcome, and the visible change develops as the tissue response progresses.
Current clinic guidance describes around 1–2 sessions for some facial treatments and 2–3 for some body treatments, depending on need.
Duration varies with the treatment plan, area treated and individual collagen response. A consultation should set expectations for your case.
Current pricing published by St Mary's Clinic. A second treatment is arranged only where follow-up assessment indicates that it is required.
Initial Lanluma treatment session following assessment and treatment planning.
The clinic currently lists a second session after approximately three months where follow-up indicates that another treatment is appropriate.
Consultation is important for deciding whether Lanluma is suitable, which areas should be treated and how the treatment should be planned.
Dr Frank Farrugia is the clinic's Lead Aesthetic Physician and is part of the aesthetic medical team at St Mary's Clinic and Redefine.
These answers are general information. Suitability, the amount of product, number of sessions and expected outcome should be discussed during consultation.
Lanluma is a PLLA collagen biostimulator. Its treatment concept is based on stimulating a gradual collagen response rather than relying only on an immediate filler-style effect.
The response develops progressively. Current clinic information notes that fuller effects may become more apparent over approximately two to three months.
The plan depends on the area and goal. Current clinic guidance describes approximately 1–2 sessions for some facial treatments and 2–3 sessions for some body treatments.
These are among the body areas currently listed by the clinic. The amount required and whether Lanluma is appropriate need to be assessed individually.
There is no single duration that can be guaranteed for every patient. Longevity varies with the treatment plan, treatment area and individual biological response.
Lanluma consultations and treatments are available at Redefine by St Mary's Clinic in Trident Park, Birkirkara, Malta.
Redefine by St Mary's Clinic
Central Business District, Triq L-Imdina, Office 7 – Level 4, Trident Park, Birkirkara, Malta